MS Emerging Markets Debt Fund Review: Emerging Market Bonds Outlook 2024
https://seekingalpha.com/article/4664214-msd-emerging-market-bonds-outlook-2024?source=feed_tag_etf_portfolio_strategy
Jan 22, 2024 - MSD is a closed-ended fixed-income fund focused on emerging markets, aiming for high income and some capital appreciation. Click here to read my analysis.
0
Do Investors Have Too Much Money Out of the Market?
https://www.fool.com/investing/2024/01/28/do-investors-have-too-much-money-out-of-the-market/?source=iedfolrf0000001
Jan 28, 2024 - We've also got a look at two stocks worth watching: Globus Medical and RPM International.
0
HSBC Faces Penalty for Failing to Protect Customer Deposits
https://www.zacks.com/stock/news/2219783/hsbc-faces-penalty-for-failing-to-protect-customer-deposits?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2219783
Feb 01, 2024 - HSBC faces a fine of 57.4 million pounds by the BoE for serious failings in its measures to protect customer deposits over several years.
0
Morgan Stanley (MS) Mulling to Offer Spot Bitcoin ETFs
https://www.zacks.com/stock/news/2234147/morgan-stanley-ms-mulling-to-offer-spot-bitcoin-etfs?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2234147
Feb 29, 2024 - Morgan Stanley (MS) is exploring the addition of spot bitcoin ETF offerings to its customers on its large brokerage platform.
0
Morgan Stanley (MS) Expands in UAE With Office in Abu Dhabi
https://www.zacks.com/stock/news/2234547/morgan-stanley-ms-expands-in-uae-with-office-in-abu-dhabi?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2234547
Mar 01, 2024 - Morgan Stanley (MS) establishes an office in Abu Dhabi to expand its footprint in the Middle East. The move is in line with its efforts to gain business opportunities from the capital markets in the region.
0
Contineum Therapeutics Seeks $150 Million IPO For MS Treatments
https://seekingalpha.com/article/4679126-contineum-therapeutics-seeks-150-million-ipo-for-ms-treatments?source=feed_tag_ipo_analysis
Mar 19, 2024 - Contineum Therapeutics plans to raise $150 million through an IPO for developing advanced medical treatments, with strong institutional support and a key...
0
Top Stock Reports for Disney, Morgan Stanley & Stryker
https://www.zacks.com/commentary/2244021/top-stock-reports-for-disney-morgan-stanley-stryker?cid=CS-ZC-FT-research_daily-2244021
Mar 21, 2024 - Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Company (DIS), Morgan Stanley (MS) and Stryker Corporation (SYK).
0
Morgan Stanley (MS) Declines More Than Market: Some Information for Investors
https://www.zacks.com/stock/news/2245173/morgan-stanley-ms-declines-more-than-market-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2245173
Mar 22, 2024 - In the most recent trading session, Morgan Stanley (MS) closed at $91.95, indicating a -1.55% shift from the previous trading day.
0
Markets Await PCE/Core-PCE Inflation Data
https://www.zacks.com/stock/news/2245569/markets-await-pce-core-pce-inflation-data?cid=CS-ZC-FT-economic_highlights-2245569
Mar 25, 2024 - Markets Await PCE/Core-PCE Inflation Data
0
Will Morgan Stanley (MS) Beat Estimates Again in Its Next Earnings Report?
https://www.zacks.com/stock/news/2252141/will-morgan-stanley-ms-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2252141
Apr 08, 2024 - Morgan Stanley (MS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0
Page 1>